Main menu
Edison Group
  • Home
  • Sparks
  • Equities

    Equities

    View All Equities

    Equities by Sector

    YXT.com

    MCap

    USD31m

    Last close

    USD5.65

    ▲ 1.12 (24.72%)

    Faraday Future Intelligent Electric

    MCap

    USD12m

    Last close

    USD4.68

    ▲ 0.86 (22.51%)

    Metals One

    MCap

    —

    Last close

    GBP0.01

    ▲ 0.18 (19.44%)

  • Sectors

    Sectors

  • Megatrends

    Megatrends

  • Thematics

    Thematics

    View All Thematics

    Latest

  • Audiovisual

    Audiovisual

    View All Audiovisual

    Latest

Sparks commentary -

Healthcare

Sparks -

Biomea Fusion’s (NASDAQ: BMEA) icovamenib shows promise in severe insulin-deficient diabetes
Published by Arron Aatkar, PhD

Biomea Fusion has reported new preclinical and clinical data from studies assessing icovamenib at the Advanced Technologies & Treatments for Diabetes 2025 conference. Notably, the data showed that, three months after the final dose of icovamenib, patients showed significant improvements in pancreatic beta-cell function, associated with a mean increase of 53% in C-peptide levels (a measure of glucose-dependent insulin secretion). The sustained effects of the therapy post-treatment highlight the potential of icovamenib as a possible disease-modifying treatment option for patients with severe insulin-deficient diabetes.

Next Sparks Commentary in this sector >

Latest

Healthcare | Comment

QBiotics launches capital raise

Industrials | Comment

JOST Werke (XETR: JST) – broad-based organic growth and deleveraging underpin confirmed FY26 outlook

Consumer | Comment

Global Fashion Group (GFG:FSE) encouraging H126 results lead to narrowing of profit guidance

Healthcare | Comment

Cereno Scientific (OMX: CRNO-B): CS1 enters Phase IIb

Consumer | Comment

Bally’s Intralot (BYLOT:ASE) evoke H126 results
Cookie Policy Overview
Edison Group

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping us understand which section of the website you find more interesting and useful. See our Cookie Policy for more information.

Strictly necessary and functional

These cookies are used to deliver our website and content. Strictly necessary cookies relate to our hosting environment, and functional cookies are used to facilitate social logins, social sharing and rich-media content embeds.

Advertising

Advertising Cookies collect information about your browsing habits such as the pages you visit and links you follow. These audience insights are used to make our website more relevant.

Performance

Performance Cookies collect anonymous information designed to help us improve the site and respond to the needs of our audiences. We use this information to make our site faster, more relevant and improve the navigation for all users.